Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PBM Psyence Biomedical Ltd

Post-Mkt 02-24 16:49:11 EST

2.23

+0.00

0.00%

盘后2.25

+0.02+0.90%

16:47 EST

High2.42	Low2.11	Vol175.87K
Open2.16	D1 Closing2.23	Amplitude14.04%
Mkt Cap2.28M	Tradable Cap2.16M	Total Shares1.02M
T/O396.98K	T/O Rate18.12%	Tradable Shares970.74K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PBM","market":"US","secType":"STK","nameCN":"Psyence Biomedical Ltd","latestPrice":2.23,"timestamp":1771966800000,"preClose":2.23,"halted":0,"volume":175868,"hourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.23,"latestTime":"16:47 EST","volume":2290,"amount":5008.230686999999,"timestamp":1771969669564,"change":0.02,"changeRate":0.008969,"amplitude":0.058296},"delay":0,"changeRate":0,"floatShares":970736,"shares":1022200,"eps":-2.105,"marketStatus":"Post-Mkt","change":0,"latestTime":"02-24 16:49:11 EST","open":2.16,"high":2.42,"low":2.107,"amount":396983.4245608,"amplitude":0.140359,"askPrice":2.44,"askSize":100,"bidPrice":2.18,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-2.105,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":2.23,"preHourTrading":{"tag":"盘前","latestPrice":2.17,"preClose":2.23,"latestTime":"09:29 EST","volume":10130,"amount":20799.15912,"timestamp":1771943399999,"change":-0.06,"changeRate":-0.026906,"amplitude":0.09417},"postHourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.23,"latestTime":"16:47 EST","volume":2290,"amount":5008.230686999999,"timestamp":1771969669564,"change":0.02,"changeRate":0.008969,"amplitude":0.058296},"volumeRatio":0.235848},"requestUrl":"/m/hq/s/PBM/wiki","defaultTab":"wiki","newsList":[{"id":"2613194127","title":"Psyence extends GoldCoast amalgamation deadline to May 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613194127","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613194127?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:42","pubTimestamp":1771936974,"startTime":"0","endTime":"0","summary":"Psyence Group Inc. has signed an amending agreement with GoldCoast Resource Corp. and its subsidiary Psyence Therapeutics Corp. to extend the timeline for their proposed three-cornered amalgamation. The deadline to hold required shareholder meetings was pushed to April 30, 2026, and the outside date to complete the deal was extended to May 31, 2026. The amendment also lowers Psyence’s minimum cash condition at closing to C$250,000 from C$400,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Group Inc. published the original content used to generate this news brief on February 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDLbSLjwn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2613183632","title":"Psyence BioMed to Invest $5 Million in PsyLabs via Share-for-Share Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2613183632","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613183632?lang=en_us&edition=fundamental","pubTime":"2026-02-21 06:20","pubTimestamp":1771626013,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. said Psyence Labs Ltd. exercised a previously disclosed put option requiring Psyence BioMed to make a $5.0 million equity investment in PsyLabs at fair market value via a non-cash share-for-share exchange. Under the terms, Psyence BioMed will receive 2,900 PsyLabs shares valued at $1,724 per share, and will issue 1,146,159 Psyence BioMed common shares to PsyLabs, priced using a 30-day VWAP of $4.36 per share. Following issuance, PsyLabs is expected to own about 49.98% of Psyence BioMed’s outstanding shares, with closing targeted on or about Feb. 25, 2026, subject to customary conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL3nq0VX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","SG9999014005.SGD","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4139","LU2210150020.SGD","SG9999014013.SGD","BK4585","PBM","BK4588","LU2210149790.SGD","NDAQ","SG9999014039.USD","BK4112"],"gpt_icon":0},{"id":"2613218888","title":"Psyence Biomed Announces Exercise of Put Option by Psylabs and Strategic Equity Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2613218888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613218888?lang=en_us&edition=fundamental","pubTime":"2026-02-21 06:20","pubTimestamp":1771626000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nTUABVCTCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2613218361","title":"Press Release: Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2613218361","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613218361?lang=en_us&edition=fundamental","pubTime":"2026-02-21 06:20","pubTimestamp":1771626000,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb. 20, 2026  -- Psyence Biomedical Ltd.  , a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that Psyence Labs Ltd., a leading developer and manufacturer of pharmaceutical-grade psychedelic compounds  has exercised its rights under a previously disclosed put option agreement , pursuant to which Psyence BioMed will make an equity investment in PsyLabs at a fair market value determined in accordance with the terms of the Put Option Agreement.The Put Option Agreement was previously disclosed by Psyence BioMed and forms part of the broader strategic and commercial relationship between the two vertically integrated companies, including licensing and supply arrangements relating to pharmaceutical-grade psychedelic compounds.No cash consideration will be exchanged in connection with the Share-for-Share Exchange. Following the issuance of the PBM Shares, PsyLabs will beneficially own approximately 4","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139","BK4588","BK4215","BK4585","EQR","API","BK4535","BK4551","BK4503","BK4023"],"gpt_icon":0},{"id":"2612486402","title":"Psyence BioMed Shareholders Approve Up to 250-for-1 Share Consolidation Authority","url":"https://stock-news.laohu8.com/highlight/detail?id=2612486402","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612486402?lang=en_us&edition=fundamental","pubTime":"2026-02-19 20:20","pubTimestamp":1771503620,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. said shareholders approved a special resolution authorizing its board to implement one or more consolidations of the company’s common shares at a ratio of up to 250-to-1. The company said it will provide additional disclosure if and when the board decides to proceed, including the final ratio and effective date, subject to applicable approvals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDLkwTrf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2612468109","title":"Psyence Biomedical announces results of annual, special meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2612468109","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612468109?lang=en_us&edition=fundamental","pubTime":"2026-02-17 22:27","pubTimestamp":1771338462,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) announced the voting results from its Annual and Special Meeting of Shareholders, held at 9:00 a.m. Eastern Time on Februa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-announces-results-of-annual-special-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-announces-results-of-annual-special-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2612450758","title":"Press Release: Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2612450758","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612450758?lang=en_us&edition=fundamental","pubTime":"2026-02-17 22:15","pubTimestamp":1771337700,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb. 17, 2026  -- Psyence Biomedical Ltd.  , a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced the voting results from its Annual and Special Meeting of Shareholders , held at 9:00 a.m. Eastern Time on February 12, 2026. Shareholders voted in favour of all matters of business presented at the Meeting, including the election of directors, the appointment of auditors and the approval of share consolidation authority for the board of directors .The Company will provide additional disclosure if and when the Board determines to implement any share consolidation, including the final consolidation ratio and effective date, subject to applicable regulatory and exchange approvals.Further details regarding the matters voted on at the Meeting are set out in the Company's management information circular, which is available under the Company's profile on EDGAR.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2611207199","title":"Psyence Biomedical board approves put option agreement with PsyLabs","url":"https://stock-news.laohu8.com/highlight/detail?id=2611207199","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611207199?lang=en_us&edition=fundamental","pubTime":"2026-02-14 07:35","pubTimestamp":1771025711,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) announced that its board of directors has ratified the entry into a put option agreement with PsyLabs, a developer and man...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-board-approves-put-option-agreement-with-psylabs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-board-approves-put-option-agreement-with-psylabs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2611199478","title":"Psyence Biomed Approves Put Option Agreement With Psylabs to Secure Strategic Supply and Strengthen Commercialization Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2611199478","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611199478?lang=en_us&edition=fundamental","pubTime":"2026-02-14 07:30","pubTimestamp":1771025402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nTUA3XYRQG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2611272198","title":"Psyence BioMed Secures Equity Option for Stake in PsyLabs","url":"https://stock-news.laohu8.com/highlight/detail?id=2611272198","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611272198?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:02","pubTimestamp":1771016525,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. has approved a put option agreement with PsyLabs, a leading manufacturer of pharmaceutical-grade psychedelic compounds. Under the agreement, PsyLabs is granted the right, but not the obligation, to require Psyence BioMed to make an additional equity investment in PsyLabs through a share-for-share exchange at fair market value, subject to specified terms and conditions. This arrangement is part of a broader strategic relationship, which also includes licensing access to PsyLabs’ manufacturing capabilities. The agreement was reviewed and ratified by a special committee of independent directors, with an independent third-party valuation considered in the decision. Key executives from Psyence BioMed collectively hold less than 13% of PsyLabs' outstanding shares. The transaction is structured to secure reliable supply and commercial alignment while preserving Psyence BioMed’s near-term financial flexibility.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL7qmmqW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2610955778","title":"BRIEF-Psyence Biomed Announces Settlement Of Shareholder Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2610955778","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610955778?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:31","pubTimestamp":1770820285,"startTime":"0","endTime":"0","summary":"BRIEF-Psyence Biomed Announces Settlement Of Shareholder LitigationFeb 11 (Reuters) - Psyence Biomedical Ltd PBM.O:PSYENCE BIOMED ANNOUNCES SETTLEMENT OF SHAREHOLDER LITIGATIONPSYENCE BIOMEDICAL LTD -","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUARNXQ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2610955321","title":"Psyence Biomedical Settles Shareholder Litigation with KAOS Capital for $1.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610955321","media":"Reuters","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610955321?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:15","pubTimestamp":1770819310,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. has settled a shareholder litigation claim brought by KAOS Capital Ltd. The dispute centered on allegations by KAOS of improper and oppressive actions by the company, which Psyence Biomedical and its leadership denied. As part of the settlement, Psyence Biomedical will pay KAOS a total of $1.5 million and will release KAOS from a prior court-ordered payment of CAD $75,000 in costs. KAOS has agreed to sell all its shares in the company to a third party at $5 per share and to fully retract its allegations. The settlement includes mutual releases of all claims and does not constitute an admission of wrongdoing by any party. The company expects to fund the settlement with cash on hand.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDLc37fR6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4112","LU2095319765.USD","SG9999014005.SGD","PBM","IE00B64PRP62.GBP","SG9999014039.USD","SG9999014021.USD","LU0314104364.USD","BK4139","LU2210150020.SGD","IE00BKPKM429.USD","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210149790.SGD","BK4588","BK4585"],"gpt_icon":0},{"id":"2610955360","title":"Psyence Biomedical Ltd - Settlement to Be Funded by Cash on Hand","url":"https://stock-news.laohu8.com/highlight/detail?id=2610955360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610955360?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:15","pubTimestamp":1770819300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUARNXQ9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2610295539","title":"Psyence Biomed Announces Settlement of Shareholder Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2610295539","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610295539?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:15","pubTimestamp":1770819300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUARNXQ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2610095535","title":"Psyence Biomedical Ltd - Co to Pay $1.5 Mln to Kaos Capital Under Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2610095535","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610095535?lang=en_us&edition=fundamental","pubTime":"2026-02-11 22:15","pubTimestamp":1770819300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUARNXQ9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2609598300","title":"Cigna's Reassurances About PBM Business Lift Stock -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2609598300","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609598300?lang=en_us&edition=fundamental","pubTime":"2026-02-06 00:47","pubTimestamp":1770310020,"startTime":"0","endTime":"0","summary":"Cigna Group's shares are up about 3% in trading Thursday, showing that investors don't think the recent round of changes out of Washington will fundamentally alter the company's outlook.Cigna is the parent of one of the largest pharmacy-benefit managers. On Wednesday, the Federal Trade Commission announced a settlement with the company. That came right after President Trump signed legislation that included new provisions designed to add transparency and other tweaks to PBMs' business.Cigna Chief Executive David Cordani told analysts on its Thursday earnings call that all of the policy moves will leave the PBM's margins, and its growth trajectory, largely unchanged, partly because it unveiled a new PBM setup last October that already incorporated an approach similar to the new requirements.The company might see a tax-rate increase of as much as 1% over time from moving one operation to the U.S., he said. He also said that Cigna expects most, but not all, clients to switch to a new PBM s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B19Z3B42.SGD","PBM","LU0868494617.USD","LU1059921491.USD","CI","IE00B19Z3581.USD","LU0289739699.SGD","BK4196","BK4585","LU0058720904.USD","BK4588","IE00BSNM7G36.USD","LU1261432733.SGD","IE0002270589.USD"],"gpt_icon":0},{"id":"2609342681","title":"CVS Health Faces New PBM Transparency Test With Earnings Engine In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2609342681","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609342681?lang=en_us&edition=fundamental","pubTime":"2026-02-05 10:39","pubTimestamp":1770259147,"startTime":"0","endTime":"0","summary":"The U.S. Department of Labor has proposed a rule that would require pharmacy benefit managers to fully disclose all compensation to self insured group health plans.\nThe rule would apply to PBMs owned by major healthcare companies, including CVS Health (NYSE:CVS).\nIf adopted, the proposal would significantly increase transparency around PBM fees, rebates, and other revenue streams.\n\nFor CVS Health, which combines retail pharmacies, insurance, and PBM operations, this proposal shines a light...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-faces-new-pbm-transparency-test-with-earnings-eng","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/cvs-health-faces-new-pbm-transparency-test-with-earnings-eng","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PBM","CVS"],"gpt_icon":0},{"id":"2608387661","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2608387661","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608387661?lang=en_us&edition=fundamental","pubTime":"2026-02-03 20:45","pubTimestamp":1770122727,"startTime":"0","endTime":"0","summary":"Julong  shares were over 22% lower pre-bell Tuesday, erasing gains from the previous session.PayPal  stock was down 15% after the company reported Q4 non-GAAP earnings and revenue that trailed analysts' estimates.Psyence Biomedical  shares were 11% lower, adding to Monday's losses.Thomson Reuters  stock was down 10% after RBC cut its price target to $155 from $177.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2290526834.HKD","BK4139","BK4129","BK4579","LU0106831901.USD","LU1861217088.USD","BK4585","LU2023251221.USD","PBM","LU1861215975.USD","TRI","LU1791807156.HKD","BK4588","PYPY","BK4535","IE00BQXX3C00.GBP","LU1989763005.USD","LU2360107671.USD","BK4566","BK7094","BK4551","BK4524","LU1668664300.SGD","BK4527","PYPL","LU1861220033.SGD","IE00BQXX3D17.EUR","LU2089284900.SGD","BK4533","BK4581","LU2360107168.USD","PYPG","LU1861220207.SGD","BK4598","BK4534","JLHL","LU2089283258.USD","BK4123","BK4227","BK4554","BK4106","LU1989773731.SGD","LU0158827948.USD","IE00BQXX3F31.USD"],"gpt_icon":0},{"id":"2608416867","title":"NASDAQ TRADE HALT CONTINUES  VOLATILITY TRADING PAUSE AT 09:31 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2608416867","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608416867?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:31","pubTimestamp":1770042696,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  VOLATILITY TRADING PAUSE AT 09:31 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nAQN2LKANJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2608048140","title":"NASDAQ TRADE HALT CONTINUES  HALT NEWS PENDING AT 03:28 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2608048140","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608048140?lang=en_us&edition=fundamental","pubTime":"2026-02-01 16:28","pubTimestamp":1769934526,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  HALT NEWS PENDING AT 03:28 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260201:nAQN2LK90T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pacificbooker.bc.ca","stockEarnings":[{"period":"1week","weight":-0.2783},{"period":"1month","weight":-0.5139},{"period":"3month","weight":-0.777},{"period":"6month","weight":-0.8853},{"period":"1year","weight":-0.9656},{"period":"ytd","weight":-0.5264}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.237918},{"month":2,"riseRate":0.4,"avgChangeRate":-0.268064},{"month":3,"riseRate":0.75,"avgChangeRate":0.142672},{"month":4,"riseRate":0.5,"avgChangeRate":-0.110088},{"month":5,"riseRate":0.5,"avgChangeRate":0.047065},{"month":6,"riseRate":0.75,"avgChangeRate":-0.123687},{"month":7,"riseRate":0.75,"avgChangeRate":0.230875},{"month":8,"riseRate":0.5,"avgChangeRate":-0.181154},{"month":9,"riseRate":0.75,"avgChangeRate":-0.153581},{"month":10,"riseRate":0.25,"avgChangeRate":-0.079288},{"month":11,"riseRate":0.25,"avgChangeRate":-0.211015},{"month":12,"riseRate":0.25,"avgChangeRate":-0.267978}],"exchange":"NASDAQ","name":"Psyence Biomedical Ltd","nameEN":"Psyence Biomedical Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Psyence Biomedical Ltd(PBM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Psyence Biomedical Ltd,PBM,Psyence Biomedical Ltd股票,Psyence Biomedical Ltd股票老虎,Psyence Biomedical Ltd股票老虎国际,Psyence Biomedical Ltd行情,Psyence Biomedical Ltd股票行情,Psyence Biomedical Ltd股价,Psyence Biomedical Ltd股市,Psyence Biomedical Ltd股票价格,Psyence Biomedical Ltd股票交易,Psyence Biomedical Ltd股票购买,Psyence Biomedical Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Psyence Biomedical Ltd(PBM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction